Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1993 2
1994 1
1996 1
1997 2
1999 1
2002 1
2003 1
2005 2
2006 1
2007 1
2008 2
2009 2
2010 1
2011 2
2012 1
2013 1
2014 1
2015 1
2016 1
2017 1
2018 1
2019 1
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Results by year
Filters applied: . Clear all
Page 1
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer.
Mehta RS, Barlow WE, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Lew DL, Hayes DF, Gralow JR, Linden HH, Livingston RB, Hortobagyi GN. Mehta RS, et al. Among authors: vandenberg ta. N Engl J Med. 2019 Mar 28;380(13):1226-1234. doi: 10.1056/NEJMoa1811714. N Engl J Med. 2019. PMID: 30917258 Free PMC article. Clinical Trial.
A practical overview of aromatase inhibitors.
Younus J, Vandenberg TA. Younus J, et al. Among authors: vandenberg ta. Anticancer Res. 2005 May-Jun;25(3c):2497-502. Anticancer Res. 2005. PMID: 16080483 Free article. Review.
Gene signatures of breast cancer progression and metastasis.
Rodenhiser DI, Andrews JD, Vandenberg TA, Chambers AF. Rodenhiser DI, et al. Among authors: vandenberg ta. Breast Cancer Res. 2011 Jan 24;13(1):201. doi: 10.1186/bcr2791. Breast Cancer Res. 2011. PMID: 21345283 Free PMC article. Review.
Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patients.
Borrie AE, Rose FA, Choi YH, Perera FE, Read N, Sexton T, Lock M, Vandenberg TA, Hahn K, Younus J, Logan D, Potvin K, Yaremko B, Yu E, Lenehan J, Welch S, Teft WA, Kim RB. Borrie AE, et al. Among authors: vandenberg ta. Breast Cancer Res Treat. 2020 Sep;183(2):365-372. doi: 10.1007/s10549-020-05777-1. Epub 2020 Jul 6. Breast Cancer Res Treat. 2020. PMID: 32632513
Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancer.
Borrie AE, Rose RV, Choi YH, Perera FE, Read N, Sexton T, Lock M, Vandenberg TA, Hahn K, Dinniwell R, Younus J, Logan D, Potvin K, Yaremko B, Yu E, Lenehan J, Welch S, Tyndale RF, Teft WA, Kim RB. Borrie AE, et al. Among authors: vandenberg ta. Breast Cancer Res Treat. 2018 Nov;172(2):371-379. doi: 10.1007/s10549-018-4910-z. Epub 2018 Aug 9. Breast Cancer Res Treat. 2018. PMID: 30094551
Combination anastrozole and fulvestrant in metastatic breast cancer.
Mehta RS, Barlow WE, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Lew DL, Hayes DF, Gralow JR, Livingston RB, Hortobagyi GN. Mehta RS, et al. Among authors: vandenberg ta. N Engl J Med. 2012 Aug 2;367(5):435-44. doi: 10.1056/NEJMoa1201622. N Engl J Med. 2012. PMID: 22853014 Free PMC article. Clinical Trial.
Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update.
Van Poznak C, Somerfield MR, Barlow WE, Biermann JS, Bosserman LD, Clemons MJ, Dhesy-Thind SK, Dillmon MS, Eisen A, Frank ES, Jagsi R, Jimenez R, Theriault RL, Vandenberg TA, Yee GC, Moy B. Van Poznak C, et al. Among authors: vandenberg ta. J Clin Oncol. 2017 Dec 10;35(35):3978-3986. doi: 10.1200/JCO.2017.75.4614. Epub 2017 Oct 16. J Clin Oncol. 2017. PMID: 29035643
Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226.
Hertz DL, Barlow WE, Kidwell KM, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Livingston RB, Gralow J, Hayes DF, Hortobagyi GN, Mehta RS, Rae JM. Hertz DL, et al. Among authors: vandenberg ta. Br J Clin Pharmacol. 2016 Jun;81(6):1134-41. doi: 10.1111/bcp.12904. Epub 2016 Apr 8. Br J Clin Pharmacol. 2016. PMID: 26859101 Free PMC article. Clinical Trial.
27 results